Esophageal dilation is commonly performed in eosinophilic esophagitis (EoE), but there are few long-term data. The aims of this study were to assess the safety and long-term effi cacy of esophageal dilation in a large cohort of EoE cases, and to determine the frequency and predictors of requiring multiple dilations.
INTRODUCTION
Eosinophilic esophagitis (EoE) is a recently recognized condition characterized clinically by symptoms of esophageal dysfunction and histologically by esophageal eosinophilia, aft er excluding secondary causes (1) (2) (3) . Common symptoms are dysphagia, food impaction, chest pain, abdominal pain, and vomiting ( 2, (4) (5) (6) . Th e prevalence of EoE has markedly increased over the past two decades (7) (8) (9) (10) (11) (12) (13) , and it is now a major contributor to health-care costs ( 14 ) .
Chronic eosinophilic infl ammation is known to cause a number of mechanical complications in the esophagus, secondary to fi brosis (15) (16) (17) . Th is infl ammatory cascade results in esophageal rings, narrowing, strictures, and mucosal fragility, termed crêpe-paper mucosa (18) (19) (20) (21) (22) (23) , which lead to clinical manifestations of
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Esophagitis: Safety, Effi cacy, and Persistence of the Fibrostenotic Phenotype dysphagia, as well as food impaction, of which EoE is now the most common cause ( 24, 25 ) . Although some anti-infl ammatory therapies may help improve fi brosis at the microscopic level ( 26, 27 ) , esophageal dilation has become an accepted mechanical therapy in EoE ( 1, 6, 20, 23, (28) (29) (30) (31) (32) (33) and can be an eff ective treatment for these symptoms ( 29, 31, (33) (34) (35) (36) . However, published experience to date with dilation remains somewhat limited ( 37, 38 ) , and there are few long-term outcomes known. In our clinical experience, many EoE patients require multiple dilations over time, but this not been extensively investigated.
Th e aims of this study were to assess the safety, effi cacy, and tolerability of esophageal dilation in a large cohort of EoE cases; to assess the outcomes; and to determine the frequency and predictors of requiring multiple dilations.
METHODS
We conducted a retrospective cohort study using the University of North Carolina EoE Clinicopathological Database. Th e details of this database have been described previously ( 23, (39) (40) (41) (42) . Th e database contains EoE cases of all ages, from March 2002 through June 2014. Briefl y, included patients met the consensus guidelines for a new diagnosis of EoE ( 1, 2 ) . Patients were required to have ≥15 eosinophils in at least one high-power fi eld, despite 8 weeks of proton-pump inhibitor therapy. Patients had to have one or more typical symptoms of esophageal dysfunction, such as dysphagia, heartburn, food impaction, or feeding intolerance, and other causes of esophageal eosinophilia were excluded. Only incident, not prevalent, cases were included.
Clinical information was extracted from the medical record on both a per-patient and per-dilation basis to determine demographics, endoscopic fi ndings, number of dilations performed, initial and fi nal esophageal diameter, type of dilator used (wireguided bougie (Savary) vs. through-the-scope (TTS) balloon), and any concomitant medical or dietary treatment. Patients were studied from the time they were diagnosed with EoE forward. If a stricture was present at diagnosis, dilation was performed if indicated. Th erefore, dilation could be performed before, aft er, or concomitantly with topical corticosteroid or dietary elimination therapy ( 1, 3 ) . Dilations were performed by the attending gastroenterologist, who also selected the dilation technique based on their preference and the clinical scenario. In general, if a focal stricture was identifi ed, standard TTS balloon technique (stationary dilation) was used. If there was a markedly narrowed esophagus or a severe stricture such that the adult upper scope would not pass, then typically a neonatal scope was used and Savary dilation was performed. If diff use narrowing or multifocal strictures were seen, the balloon pull-through technique could be utilized at the discretion of the endoscopist. In brief, this technique involves infl ation of a TTS balloon across the gastroesophageal junction, followed by slow withdrawal of the endoscope and balloon from distal to proximal esophagus ( 43 ) . If resistance is encountered, the balloon is positioned across that area and slowly reinfl ated. If no resistance is encountered, the balloon is defl ated and the esophagus is inspected for mucosal trauma. If no trauma is seen, the process is repeated with the next largest balloon diameter.
A repeat dilation was considered planned if specifi c follow-up was scheduled; it was unplanned if the indication was for recurrent symptoms aft er prior successful treatment. In general, planned follow-up was scheduled for patients with tight strictures or a diffusely narrowed esophagus. In this setting, a patient was scheduled for repeat dilation every 4-6 weeks until a symptomatic response was achieved, and the esophagus had been dilated to a diameter of at least 15 mm. However, the timing could vary based on the severity of the stricture and the concomitant EoE treatment, with shorter intervals for more severe strictures.
Complications of dilation (esophageal pain/discomfort, chest pain requiring medical attention or hospitalization, any emergency room visit, bleeding, perforation, or death) were also assessed. Postprocedure discomfort was defi ned as chest pain for which analgesics were prescribed or an emergency room visit was needed. Bleeding was defi ned as intra-or post-procedural bleeding for which the patient required endoscopic or other therapy or management in a health-care facility. Perforation was defi ned as extravasation of contrast material on esophagogram or the presence of pneumomediastinum on computed tomography scan. Measurements of esophageal luminal diameter were taken from the endoscopists' report; if it was not clearly stated, it was extrapolated from the diameter of the dilators used. Th is method has been used in prior studies of dilation in EoE ( 29, 33 ) , with the understanding that estimating the esophageal lumen can be diffi cult based on visual assessment alone ( 44 ) . Information on symptom response to dilation was obtained from medical records. Because this was a retrospective study, symptom response was dichotomized (yes/no) based on patient global report, a method that we have previously used successfully ( 41, 42 ) .
Statistical analysis was performed with Stata version 13 (Statacorp, College Station, TX), using data collected on a perpatient level, as well as a per-dilation level. Descriptive statistics were used to summarize data, and bivariate analyses were performed using Student's t -test, χ 2 , or Fisher's exact test where appropriate to compare EoE cases who did and did not require dilation. Multiple logistic regression was used to determine predictors of needing dilation. We also compared results of patients undergoing balloon vs. Savary dilation, patients who received a single dilation compared with those who required multiple dilations, and characteristics stratifi ed by provider type (senior author vs. other endoscopists). Th is study was approved by the University of North Carolina Institutional Review Board.
RESULTS

Patient and dilation characteristics
Of 509 patients identifi ed with an incident diagnosis EoE, 164 (32%) required esophageal dilation. A total of 486 dilations were performed (mean 3.0±3.7 dilations per patient). For 191 of the dilations (40%) patients were on a concomitant topical steroid, and for 73 (15%), patients were on concomitant dietary elimination therapy. (interquartile range (IQR): 5-48 months) and ranged from 0 months to 13.5 years.
Compared with EoE cases who did not require dilation, those who underwent dilation were more likely to be white (89% vs. 79%, P <0.001) and have a longer duration of symptoms before diagnosis (11.1 vs. 5.4 years, P <0.001) ( In the multivariate regression model, which included age at diagnosis, dysphagia, the presence of rings on endoscopy, an abnormal baseline endoscopy, and the absence of heartburn, the presence of dysphagia was the strongest predictor of requiring esophageal dilation (OR 8.45; 95% CI 3.45-20.7). Other factors independently associated with dilation were the absence of heartburn (OR 1.79; 95% CI 1.08-2.96), the presence of rings (OR 1.87; 95% CI 1.10-3.17), and an abnormal baseline endoscopy (OR 6.62; 95% CI 1.42-30.9). Of note, in both bivariate and multivariate analyses, the baseline eosinophil count did not predict dilation.
Safety
Post-dilation complications identifi ed included hospitalization in 2 patients (0.4%), pain requiring medical attention in 21 (4%), and emergency department evaluation in 5 (1%) ( Table 2 ). Both hospitalized patients were treated for aspiration pneumonia with antibiotics and were discharged in good condition. Th ere were no major bleeds, perforations, or deaths. Th e overall complication rate per procedure was 5%. Stratifi ed by the type of dilation, those dilated with TTS balloon dilators tended to have fewer complications ( Table 3 ), but this was not signifi cant (4% vs. 10%; P =0.10). Information on post-dilation discomfort was available for 46% (223/486) of procedures, and in these cases, 41% (91/223) reported some degree of discomfort following dilation. Th e frequency of discomfort was not diff erent for bougie vs. TTS dilators (44% vs. 40%, P =0.57).
Effi cacy and dilation technique
TTS dilators were used in 81% of procedures and wire-guided bougie dilators were used in 19%. Overall, between each patient's fi rst and last dilations, esophageal diameter improved from 12.5±3.0 to 15.2±2.9 mm ( Table 2 ). On a per-patient basis, information on symptomatic response was available for 124 patients. Of these, 108 (87%) had a symptomatic response to dilation overall. On a per-procedure basis, symptom response information was available for 153 procedures, and patients reported improved symptoms aft er 130 (85%). Symptom response was similar for those on either dietary or topical steroid therapy (88%) compared with those on neither therapy (81%). Of the 45% of patients not on concomitant medical or dietary treatment for EoE at the time of dilation, one-third of dilations occurred on high-dose proton pump inhibitor alone at the time of EoE diagnosis, and for another third patients had stopped EoE medications before their dilation due to non-adherence, expense, or because they had run out. Th ere were few diff erences in outcomes between patients who had balloon vs. bougie dilation ( Table 3 ) .
Half of the patients ( n =82) were dilated by a single provider (E.S.D.). When comparing this subgroup with those treated by the other endoscopists, there were few major diff erences in baseline clinical, endoscopic, or histologic features (data not shown). A total of 248 dilations were performed by the single provider, compared with 238 for other providers, and techniques Th ere were few clinical diff erences between those undergoing multiple dilations and a single dilation ( Table 4 ). However, those who received multiple dilations had a smaller esophageal diameter before dilation (11.3 vs. 12.5 mm, P =0.01) and ultimately achieved greater increases in esophageal diameter (4.9 vs. 3.0 mm, P <0.001). However, on a per-dilation basis, the gains were modest. For example, these individuals achieve only a 1.1-mm mean increase per session, compared with 3.0 mm in those dilated once. Th ose with multiple dilations were also more likely to have a symptomatic response to dilation (94% vs. 80%, P =0.014) and to be dilated using bougie dilators (35% vs. 19%, P =0.02).
Th ese patients also had frequent need for dilation, as the median interval between dilations was 3 months (IQR: 2-8 months). Th e median time from the fi rst to the second dilation was 4 months (IQR: 2-11 months), and the median time from fi rst to the last dilation was 14 months (IQR: 5-42 months). Overall, 75% (73/95) of those requiring multiple dilations, and 45% of the entire cohort (75/164), underwent a second dilation within 1 year. Of those receiving multiple dilations, 213 dilations (68%) were planned for continued stricture treatment; 98 dilations (32%) were provoked by patient symptoms. Sixty percent of those receiving planned dilations were on medications; among those with unplanned dilations, only 45% were on medical therapy. Information on the temporality of patients' second and third dilations is shown in Figure 1 . In addition, as the number of dilations required increased, the intervals between dilation became shorter. Th ose who required three or fewer dilations had signifi cantly longer dilation-free periods than those who required 4 or more (33 vs. 7 months, P =0.01).
DISCUSSION
Esophageal dilation is frequently utilized in EoE to treat complications of long-standing fi brostenotic disease such as rings, strictures, and a narrow-caliber esophagus ( 29, (31) (32) (33) (36) (37) (38) . Th e aims of this study were to update the safety, effi cacy, and tolerability of esophageal dilation in a large cohort of EoE cases, as well as to assess outcomes, particularly related to the frequency and predictors of requiring multiple dilations. Among our large cohort of EoE patients, about one-third required esophageal dilation. In addition, the majority of these individuals needed Runge et al.
that increases the published experience by ~50%, the procedure was both safe and eff ective. Previous studies have shown that between one-quarter and one-third of adult EoE patients require esophageal dilation ( 29, 31, 33, 36, 45 ) . In our cohort, individuals received three dilations on average per patient, which is higher than the average of 1.2-2.2 dilations per patient reported in the literature ( 29, 31, 33, 36 ) . However, a recent abstract showed that in some EoE patients, yearly dilations were required to maintain esophageal patency ( 46 ) . Our data suggest that dilation may oft en be needed at shorter intervals. Th e exact reason for multiple dilations is not clear, but possible explanations include failure of medical or dietary therapy, patient refusal or inability to tolerate chronic treatment, practice variation with dilation being performed more frequently at the index/diagnostic endoscopy, and referral patterns with EoE patients with more severe strictures being seen at our tertiary care center. Regardless of the reason, the need for multiple dilations in adult EoE patients is not necessarily unexpected. Th ere is a known association between duration of symptoms and stricture formation ( 20, 23 ) . From a mechanistic standpoint, both eosinophils and mast cells produce transforming growth factor-β , which in turn recruits fi broblasts, promotes epithelial mesenchymal transition, and increases smooth muscle contractility, all of which contribute to esophageal remodeling in EoE (15) (16) (17) 34, 37, (47) (48) (49) (50) . It is hypothesized that longstanding infl ammation and ongoing fi brotic changes result in the phenotype of strictures, rings, and narrow caliber esophagus seen in adult patients ( 17, 20, 23, 51, 52 ) . In our population with longstanding (>10 years) symptom duration before diagnosis, this may explain the frequent need for multiple dilations.
Few data are available to guide endoscopists on dilation technique ( 1, 3, 6, 53 ) , and techniques used for dilation in EoE diff er across centers, with some centers having a preference for balloons ( 29, 33 ) and others preferring bougies ( 31, 36, 54, 55 ) . Among 6 recent large studies that have reported 1,069 dilations in EoE patients, 37% were performed using balloon dilators and 63% were performed using bougies ( 29, 31, 33, 36, 54, 55 ) . Some authors suggest using bougie dilators when complex strictures or diff use multiple dilations, with more than one-fi ft h requiring four or more. Th is implies that once esophageal remodeling has occurred in EoE, it is not easily reversible even by mechanical means. We also found that over the course of nearly 500 dilations, a number Proportions total >100% as some individuals ( n =25) underwent procedures using both types of dilators. 
ESOPHAGUS
Esophageal Dilation in EoE narrowing are encountered ( 32, 52, 55, 56 ) , but others advocate the size control and direct visualization aff orded by TTS balloons ( 43, 57 ) . Our data showed that both techniques were safe and eff ective. Given similar published safety and effi cacy parameters and little comparative data on the two types of dilation, endoscopists are guided by the clinical circumstance, as well as likely their own preference and experience with dilation ( 36, 58 ) . Future studies comparing specifi c dilation methods across a variety of clinical scenarios are needed to help further guide endoscopists treating strictures in EoE.
In terms of dilation effi cacy, these methods signifi cantly increased esophageal caliber and improved symptoms in 85% of cases in which follow-up information was available. Th is proportion is comparable to that reported in the literature, which ranges from 81 to 92% ( 29, 31, 33, 37 ) . It is important to note, however, that esophageal diameter measurements were inferred from the dilator sizes used and symptomatic improvement was graded as a yes/no dichotomous variable only. For safety, we had no major complications of bleeding perforation, or death, which is also consistent with recent literature ( 57, 59, 60 ) . We also reported two hospitalizations following dilation, both due to aspiration pneumonia. Aspiration pneumonia is not necessarily a complication of dilation itself, but given the retrospective study design we could not distinguish whether the pneumonia was due to the dilation or the endoscopy. A review on esophageal dilation in EoE found an overall perforation rate of 0.6% among all published studies and a rate among recent studies of only 0.3% ( 58 ) ; similar rates were found in two meta-analyses ( 37, 38 ) . One recent prospective trial of dilation also found no major complications ( 61 ) . Of note, these fi gures are close to the overall rate of perforation from dilation quoted for any indication, 0.1-0.4% ( 53 ) .
An issue that remains unanswered is the durability of esophageal dilation in EoE. Of patients in our study who required multiple dilations, a majority (75%) required repeat dilation within 1 year, and these patients were dilated a median of 4 months aft er their fi rst dilation. Th e time frame for repeat dilation among our patients is shorter than has been seen previously ( 31 ) . Th e exact reason for this diff erence is not known, but possible explanations include differences in the dilation technique and target diameter for dilation, variability between endoscopists, incomplete control of infl ammation, and patient phenotype. Other studies suggest that repeated dilations over an "induction" period are needed for patients with severe fi brostenotic EoE ( 55 ), and we employ a similar practice in patients with severe or diff use esophageal strictures or narrowing. However, prospective studies examining the durability of dilation among distinct phenotypes of EoE patients would better practice.
Our study has several limitations. Th e fi rst is its retrospective design. Information about esophageal caliber had to be inferred from the diameter of the endoscopic equipment used. It is possible that complications could have been under-reported due to the retrospective design, as our fi gures of post-procedure pain are lower than what have been previously reported. In addition, the retrospective design of our study limited our ability to know precisely what proportion of patients derived symptomatic improvement from dilation and to what degree a patient derived improvement in tolerance of solid foods. Th e coding of symptomatic improvement as a yes/no variable meant that we could not grade the degree of symptom relief. For those who were symptom responders, we could not entirely separate the eff ect of the dilation from the eff ect of concomitant pharmacologic or dietary treatment. However, in order to mitigate this eff ect, we stratifi ed response rates by therapy and found comparable symptom response rates regardless of whether there was concomitant anti-infl ammatory therapy or not, indicating that dilation likely contributes signifi cantly to symptomatic improvement in the patients we studied. Another possible limitation is the use of diff ering dilation techniques at our center. Th ere was no standardized protocol for what type of dilator to use; instead, the type of dilator used was chosen at the discretion of the endoscopist, based on their preference and the clinical scenario. Th e balloon pull-through technique, utilized by some providers at our center, involves controlled withdrawal of an infl ated balloon from the gastroesophageal junction to the cricopharyngeus, done at increasing sizes until resistance and/or dilation eff ect are seen ( 43 ) . Th is technique can involve reintubation of the esophagus in some cases, adding time to a procedure. In addition, any balloonbased dilation technique involves increased cost. In the future, comparative studies on dilation techniques could clarify whether balloons or bougies are more eff ective in EoE. Finally, because of the specialized experience available at our center, it may be diffi cult to extrapolate the results to other practice setting, including those in the community, that are less familiar with dilation in EoE. However, even though approximately half of the dilations in this study were performed by the senior investigator (E.S.D.), there were few major diff erences between patient, dilation, and outcome characteristics by provider.
Th ese limitations are balanced by the strengths of this study, which include a large and well-characterized cohort of EoE patients, a comprehensive data extraction protocol with exhaustive follow-up information on the vast majority of individuals receiving dilation, and the largest yet reported series of esophageal dilation in EoE comprising sizable patient groups treated with both balloons and bougies.
In conclusion, our data show that esophageal dilation is a safe and eff ective treatment for relief of symptoms related to esophageal stricture, rings, or generalized narrowing in EoE patients. Approximately one-third of EoE patients require dilation, with longer duration of symptoms being an important predictor. Notably, of those who do require dilation, more than half will require multiple dilations and typically in a short time frame, a new fi nding that can be used to counsel patients who are found to have fi brostenotic complications of EoE. Future studies could address the extent to which symptoms and diet can improve with esophageal dilation, the comparative eff ectiveness of diff erent dilator types, and how anti-infl ammatory therapy following esophageal dilation may minimize the need for repeat dilation.
